Non-ownership Filings
| Tezspire Approved in EU for CRSwNP | Oct. 22, 2025 |
| US FDA Approves Tezspire in CRSwNP | Oct. 20, 2025 |
| Positive CHMP opinion for subcutaneous Saphnelo | Oct. 20, 2025 |
| Agreement with US Govt to lower medicine prices | Oct. 13, 2025 |
| Baxdrostat met primary endpoint in Bax24 Ph3 trial | Oct. 07, 2025 |
| Datroway improved OS and PFS in TROPION-Breast02 | Oct. 06, 2025 |
| Total Voting Rights | Oct. 01, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | Sep. 25, 2025 |
| Holding(s) in Company | Aug. 28, 2025 |
| Holding(s) in Company | Aug. 26, 2025 |
| Holding(s) in Company | Aug. 21, 2025 |
| Director/PDMR Shareholding | Aug. 18, 2025 |
| Holding(s) in Company | Aug. 15, 2025 |
| Holding(s) in Company | Aug. 12, 2025 |